Aurinia Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Aurinia Pharmaceuticals Inc cash flow-to-debt ratio. Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow-to-Debt Ratio of 0.29x as of June 2026, meaning its operating cash flow of $52.17 Million could theoretically repay 0% of its total liabilities ($177.40 Million) in one year. Check Aurinia Pharmaceuticals Inc (AUPH) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aurinia Pharmaceuticals Inc (1998–2025)
Cash flow-to-debt ratio of Aurinia Pharmaceuticals Inc from 1998 to 2025. Historical debt coverage capacity for Aurinia Pharmaceuticals Inc across 28 annual periods. Check Aurinia Pharmaceuticals Inc (AUPH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aurinia Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (1998–2025)
Aurinia Pharmaceuticals Inc cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Aurinia Pharmaceuticals Inc. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | $135.66 Million | $170.26 Million | ▲ +210.8% |
| 2024 | 0.26x | $44.39 Million | $173.17 Million | ▲ +230.3% |
| 2023 | -0.20x | $-33.46 Million | $170.11 Million | ▲ +83.8% |
| 2022 | -1.22x | $-79.53 Million | $65.42 Million | ▲ +50.5% |
| 2021 | -2.45x | $-157.69 Million | $64.28 Million | ▼ -96.4% |
| 2020 | -1.25x | $-69.86 Million | $55.91 Million | ▲ +49.5% |
| 2019 | -2.47x | $-63.59 Million | $25.70 Million | ▼ -59.6% |
| 2018 | -1.55x | $-51.61 Million | $33.29 Million | ▲ +9.2% |
| 2017 | -1.71x | $-41.17 Million | $24.10 Million | ▼ -92.1% |
| 2016 | -0.89x | $-18.71 Million | $21.05 Million | ▲ +31.9% |
| 2015 | -1.31x | $-17.77 Million | $13.60 Million | ▲ +43.8% |
| 2014 | -2.32x | $-16.90 Million | $7.27 Million | ▼ -405.8% |
| 2013 | -0.46x | $-4.52 Million | $9.84 Million | ▲ +55.9% |
| 2012 | -1.04x | $-6.55 Million | $6.28 Million | ▼ -508.5% |
| 2011 | -0.17x | $-1.36 Million | $7.91 Million | ▲ +84.5% |
| 2010 | -1.10x | $-4.34 Million | $3.93 Million | ▲ +50.0% |
| 2009 | -2.21x | $-10.46 Million | $4.74 Million | ▼ -138.4% |
| 2008 | -0.93x | $-17.39 Million | $18.79 Million | ▲ +53.6% |
| 2007 | -2.00x | $-28.46 Million | $14.25 Million | ▲ +0.6% |
| 2006 | -2.01x | $-21.03 Million | $10.47 Million | ▼ -13.5% |
| 2005 | -1.77x | $-21.23 Million | $11.99 Million | ▲ +21.2% |
| 2004 | -2.25x | $-20.15 Million | $8.97 Million | ▼ -157.7% |
| 2003 | -0.87x | $-5.13 Million | $5.89 Million | ▼ -220.0% |
| 2002 | -0.27x | $-849.90K | $3.12 Million | ▲ +93.3% |
| 2001 | -4.07x | $-7.25 Million | $1.78 Million | ▲ +14.6% |
| 2000 | -4.77x | $-5.77 Million | $1.21 Million | ▼ -233.7% |
| 1999 | -1.43x | $-1.36 Million | $950.74K | ▼ -95.8% |
| 1998 | -0.73x | $-1.76 Million | $2.41 Million | — |